Table 3.

Serum iron (SI), total iron binding capacity (TIBC), and transferrin saturation (TS) by treatment in mice chronically treated with DOX


Treatment

SI, μM

TIBC, μM

TS, %
Wild-type    
Saline   21.4 ± 2.9   47.6 ± 4.4   45.0 ± 6.2  
DOX     
Survivors   26.2 ± 4.9   47.2 ± 2.8   55.1 ± 9.7  
Nonsurvivors   30.5 ± 6.8*  33.3 ± 10.6*  93.0 ± 9.3* 
Hfe+/−    
Saline   31.9 ± 4.3  46.1 ± 1.8   67.0 ± 9.0 
DOX     
Survivors   25.8 ± 2.9   47.8 ± 3.7   54.0 ± 8.0  
Nonsurvivors   30.6 ± 6.8   33.4 ± 5.8*  94.5 ± 18.0* 
Hfe−/−    
Saline   41.5 ± 3.7  42.4 ± 2.1  98.0 ± 7.4 
DOX     
Survivors   39.3 ± 8.3   41.3 ± 7.4  95.0 ± 7.7  
Nonsurvivors
 
36.3 ± 10.2
 
36.6 ± 10.0
 
99.5 ± 8.1
 

Treatment

SI, μM

TIBC, μM

TS, %
Wild-type    
Saline   21.4 ± 2.9   47.6 ± 4.4   45.0 ± 6.2  
DOX     
Survivors   26.2 ± 4.9   47.2 ± 2.8   55.1 ± 9.7  
Nonsurvivors   30.5 ± 6.8*  33.3 ± 10.6*  93.0 ± 9.3* 
Hfe+/−    
Saline   31.9 ± 4.3  46.1 ± 1.8   67.0 ± 9.0 
DOX     
Survivors   25.8 ± 2.9   47.8 ± 3.7   54.0 ± 8.0  
Nonsurvivors   30.6 ± 6.8   33.4 ± 5.8*  94.5 ± 18.0* 
Hfe−/−    
Saline   41.5 ± 3.7  42.4 ± 2.1  98.0 ± 7.4 
DOX     
Survivors   39.3 ± 8.3   41.3 ± 7.4  95.0 ± 7.7  
Nonsurvivors
 
36.3 ± 10.2
 
36.6 ± 10.0
 
99.5 ± 8.1
 

Data are presented as means ± SD.

*

P < .001, comparison between saline-treated and DOX-treated mice.

P < .0001, comparison between wild-type and mutant mice with the same treatment.

P < .05, comparison between wild-type and mutant mice with the same treatment.

Close Modal

or Create an Account

Close Modal
Close Modal